CY1106582T1 - Αντικαρκινικες συνθεσεις που περιεχουν παραγωγα ταξανης - Google Patents

Αντικαρκινικες συνθεσεις που περιεχουν παραγωγα ταξανης

Info

Publication number
CY1106582T1
CY1106582T1 CY20071100643T CY071100643T CY1106582T1 CY 1106582 T1 CY1106582 T1 CY 1106582T1 CY 20071100643 T CY20071100643 T CY 20071100643T CY 071100643 T CY071100643 T CY 071100643T CY 1106582 T1 CY1106582 T1 CY 1106582T1
Authority
CY
Cyprus
Prior art keywords
compositions containing
taxane derivatives
containing taxane
cancer compositions
inhibitor
Prior art date
Application number
CY20071100643T
Other languages
English (en)
Inventor
Marie-Christine Bissery
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of CY1106582T1 publication Critical patent/CY1106582T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Στο παρόν κείμενο περιγράφονται ένα φαρμακευτικό σκεύασμα το οποίο αποτελείται από ακετοκυκλοπροπυλ taxotere ή κάποιο παράγωγο αυτού, και τουλάχιστον ένας εκ των αλκυλιωτικών παραγόντων, ένας αντιμεταβολίτης, ένας αναστολέας της μιτωτικής ατράκτου, μια επιδοφυλλοτοξίνη, ένα αντιβιοτικό, ένα ένζυμο, ένας αναστολέας τοποϊσομεράσης, ένα σύμπλεγμα συντονισμού λευκόχρυσου, ένας μετατροπέας βιολογικής αντίδρασης ή ένας αναστολέας παράγοντα ανάπτυξης.
CY20071100643T 2001-03-21 2007-05-10 Αντικαρκινικες συνθεσεις που περιεχουν παραγωγα ταξανης CY1106582T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/813,018 US6441026B1 (en) 1993-11-08 2001-03-21 Antitumor compositions containing taxane derivatives
PCT/IB2002/000853 WO2002074289A2 (en) 2001-03-21 2002-03-21 Antitumor compositions containing taxane derivatives

Publications (1)

Publication Number Publication Date
CY1106582T1 true CY1106582T1 (el) 2012-01-25

Family

ID=25211230

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100643T CY1106582T1 (el) 2001-03-21 2007-05-10 Αντικαρκινικες συνθεσεις που περιεχουν παραγωγα ταξανης

Country Status (19)

Country Link
US (1) US6441026B1 (el)
EP (1) EP1478355B1 (el)
JP (1) JP4467885B2 (el)
CN (2) CN1536995A (el)
AT (1) ATE355837T1 (el)
AU (1) AU2002244877B2 (el)
BR (1) BR0208274A (el)
CA (1) CA2440160C (el)
CY (1) CY1106582T1 (el)
DE (1) DE60218751T2 (el)
DK (1) DK1478355T3 (el)
EA (1) EA006878B1 (el)
ES (1) ES2282400T3 (el)
HU (1) HUP0500478A2 (el)
IL (1) IL157992A (el)
MX (1) MXPA03008539A (el)
PT (1) PT1478355E (el)
SI (1) SI1478355T1 (el)
WO (2) WO2002074232A2 (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
FR2698871B1 (fr) 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
BRPI0207961B8 (pt) * 2001-03-14 2021-05-25 Bristol Myers Squibb Co uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
ITRM20020191A1 (it) * 2002-04-08 2003-10-08 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie tumorali associate ad una alterata att
NZ535992A (en) * 2002-05-17 2008-11-28 Aventis Pharma Sa Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
WO2004035034A2 (en) * 2002-10-16 2004-04-29 Ilex Products, Inc. Clofarabine and taxane chemotherapy combination
ITMI20030317A1 (it) * 2003-02-21 2004-08-22 Pharmacia Italia Spa Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale.
WO2004103344A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
CN100340296C (zh) * 2005-02-03 2007-10-03 山东蓝金生物工程有限公司 一种抗癌体内植入剂
DK3248600T3 (da) * 2005-02-18 2020-07-06 Abraxis Bioscience Llc Kombinationer og måder til administration af terapeutiske stoffer og kombinationsterapi
US8735394B2 (en) * 2005-02-18 2014-05-27 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
DK2206736T3 (da) * 2005-12-05 2012-04-23 Nitto Denko Corp Polyglutamat-aminosyre-konjugater og fremgangsmåder
EP1913958B1 (en) * 2006-08-03 2009-12-23 Sanofi-Aventis Antitumor compositions containing acetylcyclopropyl docetaxel and trastuzumab
US20080181852A1 (en) * 2007-01-29 2008-07-31 Nitto Denko Corporation Multi-functional Drug Carriers
WO2008124735A2 (en) * 2007-04-10 2008-10-16 Nitto Denko Corporation Multi-functional polyglutamate drug carriers
ES2430380T3 (es) 2007-05-09 2013-11-20 Nitto Denko Corporation Composiciones que incluyen un compuesto hidrófobo y un conjugado de poliaminoácido
DK2155254T3 (da) * 2007-05-09 2013-03-04 Nitto Denko Corp Med platinlægemidler konjugerede polymere
CN101707869A (zh) * 2007-05-09 2010-05-12 日东电工株式会社 具有多种药物的聚谷氨酸盐结合物和聚谷氨酸盐-氨基酸结合物
MX2010009670A (es) * 2008-03-06 2010-09-22 Nitto Denko Corp Conjugados de paclitaxel polimericos y metodos para tratamiento de cancer.
CN105147613A (zh) 2010-03-29 2015-12-16 阿布拉科斯生物科学有限公司 增强药物递送和治疗剂有效性的方法
SG10201906075VA (en) 2010-03-29 2019-08-27 Abraxis Bioscience Llc Methods of treating cancer
WO2011153010A1 (en) 2010-06-04 2011-12-08 Abraxis Biosciences, Llc Methods of treatment of pancreatic cancer
AU2011325982C1 (en) * 2010-11-12 2015-08-20 Endocyte, Inc. Methods of treating cancer
CN102241648B (zh) * 2011-01-31 2016-08-03 沈阳东星医药科技有限公司 抗多药耐药紫杉烷类衍生物及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601676B1 (fr) 1986-07-17 1988-09-23 Rhone Poulenc Sante Procede de preparation du taxol et du desacetyl-10 taxol
FR2601675B1 (fr) 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4876399A (en) 1987-11-02 1989-10-24 Research Corporation Technologies, Inc. Taxols, their preparation and intermediates thereof
US5136060A (en) 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
US5015744A (en) 1989-11-14 1991-05-14 Florida State University Method for preparation of taxol using an oxazinone
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5645988A (en) 1991-05-08 1997-07-08 The United States Of America As Represented By The Department Of Health And Human Services Methods of identifying drugs with selective effects against cancer cells
AU2005692A (en) 1991-05-08 1992-12-21 United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Method for designing cancer treatment regimens and methods and pharmaceutical compositions for the treatment of cancer
US5229526A (en) 1991-09-23 1993-07-20 Florida State University Metal alkoxides
US5284864A (en) 1991-09-23 1994-02-08 Florida State University Butenyl substituted taxanes and pharmaceutical compositions containing them
US5262409A (en) 1991-10-11 1993-11-16 Fred Hutchinson Cancer Research Center Binary tumor therapy
US5294737A (en) 1992-02-27 1994-03-15 The Research Foundation State University Of New York Process for the production of chiral hydroxy-β-lactams and hydroxyamino acids derived therefrom
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
EP0982028A1 (en) * 1998-08-20 2000-03-01 Aventis Pharma S.A. New use of taxoid derivatives

Also Published As

Publication number Publication date
EP1478355B1 (en) 2007-03-07
DE60218751D1 (de) 2007-04-19
AU2002244877B2 (en) 2006-07-20
SI1478355T1 (sl) 2007-08-31
CN1536995A (zh) 2004-10-13
US20020031505A1 (en) 2002-03-14
CN101590057A (zh) 2009-12-02
JP4467885B2 (ja) 2010-05-26
WO2002074289A3 (en) 2004-09-02
WO2002074232A2 (en) 2002-09-26
EA200301047A1 (ru) 2004-06-24
IL157992A (en) 2008-08-07
MXPA03008539A (es) 2004-08-11
DE60218751T2 (de) 2007-11-22
BR0208274A (pt) 2004-07-13
HUP0500478A2 (hu) 2005-08-29
EP1478355A2 (en) 2004-11-24
ATE355837T1 (de) 2007-03-15
PT1478355E (pt) 2007-05-31
DK1478355T3 (da) 2007-07-02
ES2282400T3 (es) 2007-10-16
CA2440160A1 (en) 2002-09-26
WO2002074289A2 (en) 2002-09-26
JP2004536790A (ja) 2004-12-09
US6441026B1 (en) 2002-08-27
CA2440160C (en) 2011-07-05
EA006878B1 (ru) 2006-04-28

Similar Documents

Publication Publication Date Title
CY1106582T1 (el) Αντικαρκινικες συνθεσεις που περιεχουν παραγωγα ταξανης
ATE370139T1 (de) Pyrazolopyridin derivate als tgf beta hemmstoffe zur behandlung von krebs
CY1105162T1 (el) Ενωσεις και η χρηση τους ως αναστολεις 5-ητ
CY1109227T1 (el) Παραγωγα της 5-φαινυλο-4-μεθυλο-θειαζολ-2-υλ-αμινης ως αναστολεις των ενζυμων κινασης της φωσφατιδυλινοσιτολης 3 (p13) για την θεραπεια των φλεγμονωδων ασθενειων των αεραγωγων
GT200400092A (es) Preparacion y uso de derivados de alquilarilo para el tratamiento de la obesidad
UY26899A1 (es) Derivados de pirazol fusionados
DE602004008105D1 (de) 42-o-alkoxyalkylrapamycinderivate und diese enthaltende zusammensetzungen
UY26380A1 (es) Inhibidores de fab i
DE60118225D1 (de) Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren
ES2171189T3 (es) Derivados de fenilo tri-sustituidos utiles como inhibidores de pde iv.
AR011116A1 (es) Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene
ATE293995T1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
DE60211223D1 (de) Piperidinderivate als Kalium-Kanal Blockers
CY1110831T1 (el) Αντι-ιικα μεσα τυπου διαζαινδολο-δικαρβονυλο-πιπεραζινυλιου
ATE515262T1 (de) Verwendung von parthenolid-derivaten als antileukämische und zytotoxische mittel
BRPI0418255A (pt) derivados de piperazina e piperidina n-substituìdos
PT1077718E (pt) Melhoramentos da actividade de agentes antibacterianos de oxazolidinona por derivados de arginina
ATE273005T1 (de) Taxane mit carbonaten in c-4
BRPI0410663A (pt) compostos de hidroxiamidina e hidroxiguanidina como inibidores de uroquinase
ATE341321T1 (de) Zusammenstellungen enthaltend c7 taxane
PA8466101A1 (es) Agentes terapeuticos
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
DE50101515D1 (de) (p-amino-hydroxyphenyl)-acrylamid-derivate und diese verbindungen enthaltende färbemittel
NO20060509L (no) Halvfaste systemer inneholdende azetidinderivater
HUP0303589A2 (hu) Egy taxán és egy ciklin-dependens kináz inhibitor kombinációja